
Purdue Pharma’s $7B Opioid Settlement Faces Crucial Judicial Review Amid Victims’ Scrutiny
As Purdue Pharma’s $7 billion opioid settlement moves toward a judge’s approval, questions remain about accountability for the Sackler family and whether this deal truly serves the victims of America’s opioid crisis.
By Economics Desk | June 20, 2025